Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001893313 | SCV002165725 | pathogenic | not provided | 2024-06-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1127Serfs*29) in the ELP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ELP1 are known to be pathogenic (PMID: 18303054, 24173031). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1391877). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005050444 | SCV005674482 | likely pathogenic | Medulloblastoma; Familial dysautonomia | 2024-03-26 | criteria provided, single submitter | clinical testing |